CAS 114-91-0 | Pyridine, 2-(2-methoxyethyl)- | CAS Number 114-91-0

200,000+ products from a single source!

sales@angenechem.com

Product Categories

Home > Pyridines > 114-91-0

114-91-0 | Pyridine, 2-(2-methoxyethyl)-

CAS No: 114-91-0 Catalog No: AG000AA1 MDL No:MFCD00023547

Product Description

Catalog Number:

AG000AA1

Chemical Name:

Pyridine, 2-(2-methoxyethyl)-

CAS Number:

114-91-0

Molecular Formula:

C8H11NO

Molecular Weight:

137.1790

MDL Number:

MFCD00023547

IUPAC Name:

2-(2-methoxyethyl)pyridine

InChI:

InChI=1S/C8H11NO/c1-10-7-5-8-4-2-3-6-9-8/h2-4,6H,5,7H2,1H3

InChI Key:

QRBVCAWHUSTDOT-UHFFFAOYSA-N

SMILES:

COCCc1ccccn1

EC Number:

204-060-0

UNII:

08760H16R0

NSC Number:

34071

Properties

Complexity:

85.3

Compound Is Canonicalized:

Yes

Covalently-Bonded Unit Count:

Defined Atom Stereocenter Count:

Defined Bond Stereocenter Count:

Exact Mass:

137.084g/mol

Formal Charge:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Isotope Atom Count:

Molecular Weight:

137.182g/mol

Monoisotopic Mass:

137.084g/mol

Rotatable Bond Count:

Topological Polar Surface Area:

22.1A^2

Undefined Atom Stereocenter Count:

Undefined Bond Stereocenter Count:

XLogP3:

0.7

Literature

Title	Journal
Pharmacology of N-, L-, and B-subtypes of nematode nAChR resolved at the single-channel level in Ascaris suum.	FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20061201
Oxantel is an N-type (methyridine and nicotine) agonist not an L-type (levamisole and pyrantel) agonist: classification of cholinergic anthelmintics in Ascaris.	International journal for parasitology 20040801
New class of potent catalysts of O2.-dismutation. Mn(III) ortho-methoxyethylpyridyl- and di-ortho-methoxyethylimidazolylporphyrins.	Dalton transactions (Cambridge, England : 2003) 20040607
Methyridine (2-[2-methoxyethyl]-pyridine]) and levamisole activate different ACh receptor subtypes in nematode parasites: a new lead for levamisole-resistance.	British journal of pharmacology 20031101